Search Results

There are 5042 results for: content related to: Subunit-dependent inhibition and potentiation of 5- HT 3 receptor by the anticancer drug, topotecan

  1. Liposomal topotecan formulation with a low polyethylene glycol grafting density: pharmacokinetics and antitumour activity

    Journal of Pharmacy and Pharmacology

    Volume 64, Issue 3, March 2012, Pages: 372–382, Chunlei Li, Caixia Wang, Hanyu Yang, Xi Zhao, Na Wei and Jingxia Cui

    Article first published online : 16 DEC 2011, DOI: 10.1111/j.2042-7158.2011.01422.x

  2. Pharmacodynamics and pharmacokinetics of oral topotecan in patients with advanced solid tumours and impaired renal function

    British Journal of Clinical Pharmacology

    Volume 80, Issue 2, August 2015, Pages: 253–266, Lot A. Devriese, Petronella (Els). O. Witteveen, Marja Mergui-Roelvink, Deborah A. Smith, Lionel D. Lewis, David S. Mendelson, Yung-Jue Bang, Hyun Choel Chung, Mohammed M. Dar, Alwin D. R. Huitema, Jos H. Beijnen, Emile E. Voest and Jan H. M. Schellens

    Article first published online : 20 MAY 2015, DOI: 10.1111/bcp.12606

  3. Topotecan for ovarian cancer

    Intervention Review

    The Cochrane Library

    Peng Lihua, Xiao Y Chen and Taixiang Wu

    Published Online : 23 APR 2008, DOI: 10.1002/14651858.CD005589.pub2

  4. Serotonin receptor diversity in the human colon: Expression of serotonin type 3 receptor subunits 5-HT3C, 5-HT3D, and 5-HT3E

    Journal of Comparative Neurology

    Volume 519, Issue 3, 15 February 2011, Pages: 420–432, Johannes Kapeller, Dorothee Möller, Felix Lasitschka, Frank Autschbach, Ruud Hovius, Gudrun Rappold, Michael Brüss, Michael D. Gershon and Beate Niesler

    Article first published online : 29 DEC 2010, DOI: 10.1002/cne.22525

  5. Small-Cell Lung Cancer

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 15 SEP 2006, DOI: 10.1002/9780470041000.cedt016

  6. Pelitinib (EKB-569) targets the up-regulation of ABCB1 and ABCG2 induced by hyperthermia to eradicate lung cancer

    British Journal of Pharmacology

    Volume 172, Issue 16, August 2015, Pages: 4089–4106, Kenneth K W To, Daniel C Poon, Yuming Wei, Fang Wang, Ge Lin and Liwu Fu

    Article first published online : 26 JUN 2015, DOI: 10.1111/bph.13189

  7. You have free access to this content
    Reversal of breast cancer resistance protein (BCRP/ABCG2)-mediated drug resistance by novobiocin, a coumermycin antibiotic

    International Journal of Cancer

    Volume 108, Issue 1, 1 January 2004, Pages: 146–151, Ken Shiozawa, Mikio Oka, Hiroshi Soda, Megumi Yoshikawa, Yoji Ikegami, Junji Tsurutani, Katsumi Nakatomi, Yoichi Nakamura, Seiji Doi, Takeshi Kitazaki, Yohei Mizuta, Kunihiko Murase, Hisahiro Yoshida, Douglas D. Ross and Shigeru Kohno

    Article first published online : 24 SEP 2003, DOI: 10.1002/ijc.11528

  8. Comparison of the efficacy between topotecan- and belotecan-, a new camptothecin analog, based chemotherapies for recurrent epithelial ovarian cancer: A single institutional experience

    Journal of Obstetrics and Gynaecology Research

    Volume 36, Issue 1, February 2010, Pages: 86–93, Hee Seung Kim, Noh Hyun Park, Sokbom Kang, Sang-Soo Seo, Hyun Hoon Chung, Jae Weon Kim, Yong Sang Song and Soon-Beom Kang

    Article first published online : 4 FEB 2010, DOI: 10.1111/j.1447-0756.2009.01101.x

  9. You have free access to this content
    Phase 2 study of intraperitoneal topotecan as consolidation chemotherapy in ovarian and primary peritoneal carcinoma


    Volume 113, Issue 3, 1 August 2008, Pages: 490–496, Howard G. Muntz, Thomas W. Malpass, Kathryn F. McGonigle, Mandy D. Robertson and Paul L. Weiden

    Article first published online : 2 JUN 2008, DOI: 10.1002/cncr.23576

  10. A phase-1 pharmacokinetic optimal dosing study of intraventricular topotecan for children with neoplastic meningitis: A pediatric brain tumor consortium study

    Pediatric Blood & Cancer

    Volume 60, Issue 4, April 2013, Pages: 627–632, Susan M. Blaney, Michael Tagen, Arzu Onar-Thomas, Stacey L. Berg, Sri Gururangan, Kathleen Scorsone, Jack Su, Stewart Goldman, Mark W. Kieran, Larry Kun, Jim Boyett and Clinton Stewart

    Article first published online : 21 SEP 2012, DOI: 10.1002/pbc.24309

  11. You have free access to this content
    Oral topotecan in children with recurrent or progressive high-grade glioma


    Volume 100, Issue 8, 15 April 2004, Pages: 1750–1757, Sabine Wagner, Bernhard Erdlenbruch, Alfred Längler, Astrid Gnekow, Joachim Kühl, Michael Albani, Sigrid Völpel, Peter Bucsky, Angela Emser, Ove Peters and Johannes E. A. Wolff

    Article first published online : 11 MAR 2004, DOI: 10.1002/cncr.20168

  12. Phase I/II study of tandem cycles of high-dose chemotherapy followed by autologous hematopoietic stem cell support in women with advanced ovarian cancer

    International Journal of Gynecological Cancer

    Volume 16, Issue 1, January 2006, Pages: 57–64, A. TIERSTEN, M. SELLECK, D.H. SMITH, I. WERTHEIM, E. KAUFMAN, D. HERSHMAN, L.T. VAHDAT, D.G. SAVAGE, R.B. MACARTHUR and C. HESDORFFER

    Article first published online : 24 JAN 2006, DOI: 10.1111/j.1525-1438.2006.00278.x

  13. Effect of stealthy liposomal topotecan plus amlodipine on the multidrug-resistant leukaemia cells in vitro and xenograft in mice

    European Journal of Clinical Investigation

    Volume 36, Issue 6, June 2006, Pages: 409–418, X. Li, W. L. Lu, G. W. Liang, G. R. Ruan, H. Y. Hong, C. Long, Y. T. Zhang, Y. Liu, J. C. Wang, X. Zhang and Q. Zhang

    Article first published online : 8 MAY 2006, DOI: 10.1111/j.1365-2362.2006.01643.x

  14. Early CA-125 fluctuations in patients with recurrent ovarian cancer receiving chemotherapy

    International Journal of Gynecological Cancer

    Volume 17, Issue 3, May/June 2007, Pages: 589–594, P. SABBATINI, D. MOONEY, A. IASONOS, H. THALER, C. AGHAJANIAN, M. HENSLEY, J. KONNER, D. SPRIGGS, N.R. ABU-RUSTUM and J. DUPONT

    Article first published online : 9 FEB 2007, DOI: 10.1111/j.1525-1438.2007.00823.x

  15. Retinoic acid treatment and cell aggregation independently regulate alternative splicing in P19 cells during neural differentiation

    Cell Biology International

    Volume 34, Issue 6, June 2010, Pages: 631–643, AHM Khurshid Alam, Hitoshi Suzuki and Toshifumi Tsukahara

    Article first published online : 29 SEP 2014, DOI: 10.1042/CBI20090332

  16. You have free access to this content
    Phase II study of topotecan in combination with dexamethasone, asparaginase, and vincristine in pediatric patients with acute lymphoblastic leukemia in first relapse


    Volume 112, Issue 9, 1 May 2008, Pages: 1983–1991, Nobuko Hijiya, Clinton F. Stewart, Yinmei Zhou, Dario Campana, Elaine Coustan-Smith, Gaston K. Rivera, Mary V. Relling, Ching-Hon Pui and Amar Gajjar

    Article first published online : 4 MAR 2008, DOI: 10.1002/cncr.23395

  17. You have free access to this content
    A prospective randomized trial of thalidomide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian carcinoma


    Volume 112, Issue 2, 15 January 2008, Pages: 331–339, Levi S. Downs Jr., Patricia L. Judson, Peter A. Argenta, Rahel Ghebre, Melissa A. Geller, Robin L. Bliss, Matthew P. Boente, William A. Nahhas, Samir Z. Abu-Ghazaleh, M. Dwight Chen and Linda F. Carson

    Article first published online : 30 NOV 2007, DOI: 10.1002/cncr.23164

  18. You have full text access to this OnlineOpen article
    Discriminating between 5-HT3A and 5-HT3AB receptors

    British Journal of Pharmacology

    Volume 169, Issue 4, June 2013, Pages: 736–747, AJ Thompson and SCR Lummis

    Article first published online : 27 MAY 2013, DOI: 10.1111/bph.12166

  19. Initial testing of topotecan by the pediatric preclinical testing program

    Pediatric Blood & Cancer

    Volume 54, Issue 5, May 2010, Pages: 707–715, Hernan Carol, Peter J. Houghton, Christopher L. Morton, E. Anders Kolb, Richard Gorlick, C. Patrick Reynolds, Min H. Kang, John M. Maris, Stephen T. Keir, Amy Watkins, Malcolm A. Smith and Richard B. Lock

    Article first published online : 16 DEC 2009, DOI: 10.1002/pbc.22352

  20. Mechanism-based models for topotecan-induced neutropenia

    Clinical Pharmacology & Therapeutics

    Volume 76, Issue 6, December 2004, Pages: 567–578, Frédéric Léger, Walter J. Loos, Roland Bugat, Ron H. J. Mathijssen, Marine Goffinet, Jaap Verweij, Alex Sparreboom and Etienne Chatelut

    Article first published online : 3 DEC 2004, DOI: 10.1016/j.clpt.2004.08.008